CLINICAL OUTCOMES OF LETROZOLE VERSUS CLOMIPHENE CITRATE IN OVULATION INDUCTION THERAPY

Main Article Content

Humaira Alam
Sayeba Akhter
Nigar Sultana
Kazi Farhana Begum

Keywords

Letrozole, Clomiphene Citrate, Ovulation Induction, PCOS, Infertility.

Abstract

Clomiphene citrate has long been the standard treatment for ovulation induction in women with polycystic ovarian syndrome (PCOS); however, its antiestrogenic effects and resistance issues limit its efficacy. Letrozole, an aromatase inhibitor, has emerged as a promising alternative treatment. This study aimed to compare the clinical outcomes of letrozole versus clomiphene citrate in ovulation induction therapy among infertile women with PCOS in a Bangladeshi tertiary care setting.


Methods: This randomized controlled trial was conducted at the Department of Obstetrics and Gynaecology, Bangabandhu Sheikh Mujib Medical University, Dhaka, from January 2009 to December 2010. A total of 500 women (250 per group) with anovulatory infertility received either 2.5 mg letrozole or 50 mg Clomiphene citrate from days 2 to 6 of their menstrual cycle. The primary outcomes included ovulation rate, endometrial thickness, clinical pregnancy rate, and live birth rate. Results: Letrozole showed a significantly higher ovulation rate (76.8% vs. 61.2%, p=0.001), thicker endometrium (8.9 mm vs. 7.4 mm, p<0.001), and improved clinical pregnancy (29.2% vs. 19.6%, p=0.01) and live birth rates (24.8% vs. 16.0%, p=0.02) than Clomiphene citrate. Adverse effects were more common in the Clomiphene citrate group.


Conclusion: Letrozole is more effective and better tolerated than clomiphene citrate for ovulation induction and should be considered a first-line option for the treatment of anovulatory infertility in similar clinical settings.

Abstract 26 | Pdf Downloads 11

References

1. Zegers-Hochschild F, Adamson GD, De Mouzon J, Ishihara O, Mansour R, Nygren K, Sullivan E, Van der Poel S. The international committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary on ART terminology, 2009. Human reproduction. 2009 Nov 1;24(11):2683-7.
2. Balen AH, Tan SL, Jacobs HS. Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. BJOG: An International Journal of Obstetrics & Gynaecology. 1993 Dec;100(12):1082-9.
3. Saxena P, Prakash A, Nigam A, Mishra A. Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index. Indian journal of endocrinology and metabolism. 2012 Nov 1;16(6):996-9.
4. FRANKS S, ADAMS J, MASON H, POLSON D. Ovulatory disorders in women with polycystic ovary syndrome. Clinics in obstetrics and gynaecology. 1985 Sep 1;12(3):605-32.
5. Kistner RW. Induction of ovulation with clomiphene citrate (clomid). Obstet Gynecol Surv. 1965 Dec;20(6):873-900.
6. Dickey RP, Olar TT, Taylor SN, Curole DN, Matulich EM. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertility and sterility. 1993 Apr 1;59(4):756-60.
7. Casper RF. Letrozole versus clomiphene citrate: which is better for ovulation induction? Fertility and sterility. 2009 Sep 1;92(3):858-9.
8. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertility and sterility. 2001 Feb 1;75(2):305-9.
9. El Bigawy AF, Fouda UM, Wahab HA. A randomized trial of letrazole versus clomiphene citrate in induction of ovulation in patients with polycystic ovary syndrome (PCOS).
10. Zeinalzadeh M, Basirat Z, Esmailpour M. Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. The Journal of reproductive medicine. 2010 Jan 1;55(1-2):36-40.
11. Al-Fozan H, Al-Khadouri M, Tan SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertility and sterility. 2004 Dec 1;82(6):1561-3.
12. Ivy R, Chowdhury A, Haque K, Ara H. Aromatase Inhibitor for Ovulation Induction: A Comparative Study Between Letrozole and Clomiphen Citrate in Anovulatory Infertile Women. Bangladesh Journal of Physiology and Pharmacology. 2009:10-2.
13. Begum MR, Quadir E, Begum A, Begum RA, Begum M. Role of aromatase inhibitor in ovulation induction in patients with poor response to clomiphene citrate. Journal of Obstetrics and Gynaecology Research. 2006 Oct;32(5):502-6.
14. Banerjee Ray P, Ray A, Chakraborti PS. Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome. Archives of gynecology and obstetrics. 2012 Mar;285(3):873-7.
15. Atay V, Cam C, Muhcu M, Cam M, Karateke A. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of international medical research. 2006 Jan;34(1):73-6.
16. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertility and sterility. 2002 Aug 1;78(2):280-5.
17. Sammour A, Biljan MM, Tan SL, Tulandi T. Prospective randomized trial comparing the effects of letrazole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation prior to intrauterine insemination (IUI). Fertility and Sterility. 2001 Sep 1;76(3): S110.
18. Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Human Reproduction. 1990 Aug 1;5(6):670-4.
19. Hussain NH, Ismail M, Zain MM, Yeu PC, Ramli R, Mohammad WM. Randomized controlled trial of Letrozole versus Clomiphene citrate for induction of ovulation in polycystic ovarian syndrome (PCOS): a Malaysian experience.
20. Aletebi F, Alaa N. The effect of letrozole versus clomiphene citrate on ovulation induction in polycystic ovarian syndrome patients: RCT. Journal of Evidence-Based Women’s Health Journal Society. 2013 May 1;3(2):51-3.
21. Hajishafieiha M, Poorfarzan L, Kiarang N. Comparing the clinical effects of letrozol vs clomifene in infertile ovulator women (borderline male factor infertility, and unexplained infertility) undergoing intrauterine in semination. Studies in Medical Sciences. 2009 Jun 10;20(1):8-12.
22. Cortínez A, De Carvalho I, Vantman D, Gabler F, Iñiguez G, Vega M. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertility and sterility. 2005 Jan 1;83(1):110-5.
23. Bayar Ü, Tanrıverdi HA, Barut A, Ayoğlu F, Özcan O, Kaya E. Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertility and sterility. 2006 Apr 1;85(4):1045-8.